Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jenner

Showing results (31-40 of 548) with videos related to

Pageof 55
Sort By:
Journal of Neurochemistry|December 3, 1999
Altered glial function causes neuronal death and increases neuronal susceptibility to 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced toxicity in astrocytic/ventral mesencephalic co-culturesK S McNaught, P Jenner
Psychological Medicine|February 1, 1980
The pathophysiology of extrapyramidal side-effects of neuroleptic drugsC D Marsden, P Jenner
International Journal of Clinical Pharmacology and Biopharmacy|July 1, 1975
Metabolic N-oxidation products of aliphatic amines as potential mediators in amine pharmacologyJ W Gorrod, P Jenner
Neuropharmacology|December 1, 1981
Substituted benzamide drugs as selective neuroleptic agentsP Jenner, C D Marsden
Life Sciences|August 6, 1979
The substituted benzamides--a novel class of dopamine antagonistsP Jenner, C D Marsden
Neuropharmacology|July 1, 1987
Chronic pharmacological manipulation of dopamine receptors in brainP Jenner, C D Marsden
Advances in Neurology|January 1, 1988
Adaptive changes in brain dopamine function as a result of neuroleptic treatmentP Jenner, C D Marsden
Neuroscience Letters|January 4, 2001
Proteasomal function is impaired in substantia nigra in Parkinson's diseaseK S McNaught, P Jenner
Biochemical Pharmacology|September 7, 2000
Extracellular accumulation of nitric oxide, hydrogen peroxide, and glutamate in astrocytic cultures following glutathione depletion, complex I inhibition, and/or lipopolysaccharide-induced activationK S McNaught, P Jenner
Acta Psychiatrica Belgica|September 1, 1987
Neuroleptic-induced tardive dyskinesiaP Jenner, C D Marsden
Pageof 55

Showing results (31-40 of 548) with videos related to

Sort By:
Pageof 55
Journal of Neurochemistry|December 3, 1999
Altered glial function causes neuronal death and increases neuronal susceptibility to 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced toxicity in astrocytic/ventral mesencephalic co-culturesK S McNaught, P Jenner
Psychological Medicine|February 1, 1980
The pathophysiology of extrapyramidal side-effects of neuroleptic drugsC D Marsden, P Jenner
International Journal of Clinical Pharmacology and Biopharmacy|July 1, 1975
Metabolic N-oxidation products of aliphatic amines as potential mediators in amine pharmacologyJ W Gorrod, P Jenner
Neuropharmacology|December 1, 1981
Substituted benzamide drugs as selective neuroleptic agentsP Jenner, C D Marsden
Life Sciences|August 6, 1979
The substituted benzamides--a novel class of dopamine antagonistsP Jenner, C D Marsden
Neuropharmacology|July 1, 1987
Chronic pharmacological manipulation of dopamine receptors in brainP Jenner, C D Marsden
Advances in Neurology|January 1, 1988
Adaptive changes in brain dopamine function as a result of neuroleptic treatmentP Jenner, C D Marsden
Neuroscience Letters|January 4, 2001
Proteasomal function is impaired in substantia nigra in Parkinson's diseaseK S McNaught, P Jenner
Biochemical Pharmacology|September 7, 2000
Extracellular accumulation of nitric oxide, hydrogen peroxide, and glutamate in astrocytic cultures following glutathione depletion, complex I inhibition, and/or lipopolysaccharide-induced activationK S McNaught, P Jenner
Acta Psychiatrica Belgica|September 1, 1987
Neuroleptic-induced tardive dyskinesiaP Jenner, C D Marsden
Pageof 55